In the present study, we demonstrated that knockdown of CGREF1 resulted in inhibition of GSK3β phosphorylation, reduction in β-catenin protein levels, and suppression of downstream Cyclin D activation by β-catenin, consequently leading to impaired proliferation ability of osteosarcoma cells. The gene discussed is GSK3B; the disease is osteosarcoma.